1. 2022
  2. Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathy

    Amaador, K., Wieske, L., Koel-Simmelink, M. J. A., Kamp, A., Jongerius, I., de Heer, K., Teunissen, C. E., Minnema, M. C., Notermans, N. C., Eftimov, F., Kersten, M. J. & Vos, J. M. I., Jul 2022, In: Journal of neurology. 269, 7, p. 3700-3705 6 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. High frequency of central nervous system involvement in transformed Waldenstrom € macroglobulinemia

    Durot, E., Kanagaratnam, L., Zanwar, S., Toussaint, E., Kastritis, E., D’Sa, S., Alcoceba, M., Tomowiak, C., Hivert, B., Protin, C., Abeykoon, J. P., Vos, J. M. I., Michallet, A-S., Rodier, C., Dupuis, J., Leprêtre, S., Merabet, F., Roussel, X., Zini, J-M., Regny, C., & 9 othersPatel, A., Morel, P., Roos-Weil, D., Treon, S. P., Dimopoulos, M. A., Garcia-Sanz, R., Kapoor, P., Castillo, J. J. & Delmer, A. J., 28 Jun 2022, In: Blood advances. 6, 12, p. 3655-3658 4 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  4. Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

    Iacoboni, G., Rejeski, K., Villacampa, G., van Doesum, J. A., Chiappella, A., Bonifazi, F., Lopez-Corral, L., van Aalderen, M., Kwon, M., Martınez-Cibrian, N., Bramanti, S., Reguera-Ortega, J. L., Camacho-Arteaga, L., Schmidt, C., Marın-Niebla, A., Kersten, M. J., Garcia-Sancho, A. M., Zinzani, P. L., Corradini, P., van Meerten, T., & 2 othersSubklewe, M. & Barba, P., 28 Jun 2022, In: Blood advances. 6, 12, p. 3606-3610 5 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  5. The EHA Research Roadmap: Malignant Lymphoid Diseases

    Dreyling, M., André, M., Gökbuget, N., Tilly, H., Jerkeman, M., Gribben, J., Ferreri, A., Morel, P., Stilgenbauer, S., Fox, C., Maria Ribera, J., Zweegman, S., Aurer, I., Bödör, C., Burkhardt, B., Buske, C., Dollores Caballero, M., Campo, E., Chapuy, B., Davies, A., & 34 othersde Leval, L., Doorduijn, J., Federico, M., Gaulard, P., Gay, F., Ghia, P., Grønbæk, K., Goldschmidt, H., Kersten, M-J., Kiesewetter, B., Landman-Parker, J., le Gouill, S., Lenz, G., Leppä, S., Lopez-Guillermo, A., Macintyre, E., Mantega, M. V. M., Moreau, P., Moreno, C., Nadel, B., Okosun, J., Owen, R., Pospisilova, S., Pott, C., Robak, T., Spina, M., Stamatopoulos, K., Stary, J., Tarte, K., Tedeschi, A., Thieblemont, C., Trappe, R. U., Trümper, L. H. & Salles, G., 19 Jun 2022, In: HemaSphere. 6, 6, p. E726

    Research output: Contribution to journalReview articleAcademicpeer-review

  6. Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial

    HOVON Stem Cell Transplantation Working Group, 14 Jun 2022, In: Blood advances. 6, 11, p. 3378-3385 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial

    Kater, A. P., Levin, M-D., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., van der Kevie-Kersemaekers, A-M. F., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Brieghel, C., Mattsson, M., Bellido, M., Tran, H. T. T., & 2 othersNasserinejad, K. & Niemann, C. U., 1 Jun 2022, In: The Lancet Oncology. 23, 6, p. 818-828 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. T-cell subset composition and functionality in patients with Waldenström's macroglobulinemia

    Amaador, K., Martens, A., de Boer, R., Rietveld, J., Heemskerk, M., Rutten, C. E., Eldering, E., Kersten, M-J., Kater, A. P., Vos, J. & Tonino, S., Jun 2022, In: Leukemia & lymphoma. 63, 6, p. 1469-1473 5 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Uw diagnose?

    Kwakernaak, A. J., Bernelot Moens, S. J., Hilhorst, M. L., Florquin, S., van de Donk, N. C. W. J. & Vos, J. M., Jun 2022, In: Nederlandse Vereniging voor Trombose en Haemostase (NVTH).

    Research output: Contribution to journalArticleProfessional

  10. Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study

    Wang, M., Munoz, J., Goy, A., Locke, F. L., Jacobson, C. A., Hill, B. T., Timmerman, J. M., Holmes, H., Jaglowski, S., Flinn, I. W., Mcsweeney, P. A., Miklos, D. B., Pagel, J. M., Kersten, M. J., Bouabdallah, K., Khanal, R., Topp, M. S., Houot, R., Beitinjaneh, A., Peng, W., & 5 othersFang, X., Shen, R. R., Siddiqi, R., Kloos, I. & Reagan, P. M., 1 May 2022, In: Journal of clinical oncology. 94, 02370.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Time to evolve: predicting engineered T cell-associated toxicity with next-generation models

    Donnadieu, E., Luu, M., Alb, M., Anliker, B., Arcangeli, S., Bonini, C., de Angelis, B., Choudhary, R., Espie, D., Galy, A., Holland, C., Ivics, Z., Kantari-Mimoun, C., Kersten, M. J., Köhl, U., Kuhn, C., Laugel, B., Locatelli, F., Marchiq, I., Markman, J., & 14 othersMoresco, M. A., Morris, E., Negre, H., Quintarelli, C., Rade, M., Reiche, K., Renner, M., Ruggiero, E., Sanges, C., Stauss, H., Themeli, M., van den Brulle, J., Hudecek, M. & Casucci, M., 1 May 2022, In: Journal for immunotherapy of cancer. 10, 5

    Research output: Contribution to journalReview articleAcademicpeer-review

Previous 1...4 5 6 7 8 9 10 11 ...130 Next

ID: 19903